The deal is non-binding and subject to multiple conditions (shareholder approval, SEC/Nasdaq approvals). Monitor for a definitive merger agreement and the completion of the Cove Kaz distribution, which is a prerequisite to closing.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 12 $1.16entry
- T+1 · 5d ago −37.45%α −37.09% · $0.7256
- T+3 · todayOpen
- T+5 · tomorrow Pending
- T+20 · in 23d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Skyline Builders Group (CRMN) announced a non-binding term sheet to acquire SuperCritical Materials, a developer of uranium extraction from seawater technology. The deal would give Skyline 51% ownership, with SuperCritical shareholders holding 44% and new investors 5% via a $10M private placement. The transaction is expected to close in Q1 2027, after the distribution of Cove Kaz value to Skyline shareholders.
Key Facts
- Skyline entered a non-binding term sheet to acquire SuperCritical Materials, a developer of uranium and critical metals extraction from seawater technology.
- Skyline would own 51% of the combined entity; SuperCritical shareholders 44%; new investors (via $10M private placement) 5%.
- The transaction is expected to close in Q1 2027, after the distribution of Cove Kaz value to Skyline shareholders (expected in Q4 2026).
- SuperCritical holds an exclusive commercial license to uranium-selective adsorbent technology developed by U.S. DOE's Pacific Northwest National Laboratory.
- Strategic and institutional investors, including American Ventures, have provided approximately $4.5 million of funding to SuperCritical in the last 12 months.
- The term sheet is non-binding; definitive agreements and shareholder/regulatory approvals are required.
Financial Impact
Skyline to own 51% of combined entity; $10M private placement into SuperCritical for 5% stake; SuperCritical received ~$4.5M in funding over past 12 months.
Risk Factors
- Non-binding term sheet; transaction may not be completed on terms described or at all.
- Requires shareholder approval, SEC and Nasdaq approvals, including a new listing application.
- Closing depends on prior distribution of Cove Kaz value, which itself is subject to timing and tax efficiency.
- SuperCritical's technology is pre-commercial; economic feasibility at industrial scale not yet established.
- Forward-looking statements subject to numerous risks and uncertainties.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3401591 |
Track record
11 reports on KAZR
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 12, 20265d ago 6-K Neutral 4/10 Entry $1.16 Now $0.9600 −17.24% settles Nov 19
- Nov 12, 20265d ago 6-K Neutral 2/10 Entry $1.16 Now $0.9600 −17.24% settles Nov 19
- Nov 12, 20265d ago Press Release Neutral 4/10 Viewing Entry $1.16 Now $0.9600 −17.24% settles Nov 19
- Nov 12, 20265d ago Press Release Neutral 2/10 Entry $1.16 Now $0.9600 −17.24% settles Nov 19
- Nov 2, 202615d ago 6-K Bullish 7/10 Entry $1.27 to $1.31 Now $0.9600 −24.41% ▲ +3.15% +3.07% vs SPY
- Nov 2, 202615d ago Press Release Bullish 7/10 Entry $1.27 to $1.31 Now $0.9600 −24.41% ▲ +3.15% +3.07% vs SPY
- Aug 17, 202613w ago 425 Neutral 3/10 Entry $2.13 to $1.95 Now $0.9600 −54.93% ▼ −8.45% −8.25% vs SPY
- Aug 17, 202613w ago 6-K Neutral 3/10 Entry $2.13 to $1.95 Now $0.9600 −54.93% ▼ −8.45% −8.25% vs SPY
- Aug 11, 202614w ago 425 Neutral 4/10 Entry $2.22 to $2.05 Now $0.9600 −56.76% ▼ −7.66% −7.21% vs SPY
- Aug 11, 202614w ago 6-K Neutral 3/10 Entry $2.30 to $2.13 Now $0.9600 −58.26% ▼ −7.39% −6.99% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers